The CVS stock outlook improved further on Tuesday after CVS Health raised its 2025 profit guidance for the fourth time this year and projected earnings growth for 2026, signaling continued progress in the company’s financial turnaround under CEO David Joyner. Shares of CVS have risen more than 70% in 2025, reflecting renewed investor confidence after several years of operational challenges and margin pressure across the company’s core businesses.

Read more here